Nesma HOUMANI

Dr. Nesma HOUMANI

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NHNesma HOUMANI
Nesma HOUMANI
FVFrançois Vialatte
François Vialatte
EGEsteve Gallego-Jutglà
Esteve Gallego-Jutglà
GDGérard Dreyfus
Gérard Dreyfus
VNVi-Huong Nguyen-Michel
Vi-Huong Nguyen-Michel
KKKiyoka Kinugawa
Kiyoka Kinugawa
This study addresses the problem of Alzheimer’s disease (AD) diagnosis with Electroencephalography (EEG). The use of EEG as a tool for AD diagnosis has been widely studied by comparing EEG signals of AD patients only to those of healthy subjects. By contrast, we perform automated EEG diagnosis in a differential diagnosis context using a new database, acquired in clinical conditions, which contains EEG data of 169 patients: subjective cognitive impairment (SCI) patients, mild cognitive impairment (MCI) patients, possible Alzheimer’s disease (AD) patients, and patients with other pathologies. We show that two EEG features, namely epoch-based entropy (a measure of signal complexity) and bump modeling (a measure of synchrony) are sufficient for efficient discrimination between these groups. We studied the performance of our methodology for the automatic discrimination of possible AD patients from SCI patients and from patients with MCI or other pathologies. A classification accuracy of 91.6% (specificity = 100%, sensitivity = 87.8%) was obtained when discriminating SCI patients from possible AD patients and 81.8% to 88.8% accuracy was obtained for the 3-class classification of SCI, possible AD and other patients.

22 November 2021 in Entropy
Verified
Journal Article
Open access
PDF file
MAMAJD ABAZID
MAJD ABAZID
NHNesma HOUMANI
Nesma HOUMANI
JBJérôme Boudy
Jérôme Boudy
BDBernadette Dorizzi
Bernadette Dorizzi
JMJEAN MARIANI
JEAN MARIANI
KKKiyoka Kinugawa
Kiyoka Kinugawa
This work addresses brain network analysis considering different clinical severity stages of cognitive dysfunction, based on resting-state electroencephalography (EEG). We use a cohort acquired in real-life clinical conditions, which contains EEG data of subjective cognitive impairment (SCI) patients, mild cognitive impairment (MCI) patients, and Alzheimer’s disease (AD) patients. We propose to exploit an epoch-based entropy measure to quantify the connectivity links in the networks. This entropy measure relies on a refined statistical modeling of EEG signals with Hidden Markov Models, which allow a better estimation of the spatiotemporal characteristics of EEG signals. We also propose to conduct a comparative study by considering three other measures largely used in the literature: phase lag index, coherence, and mutual information. We calculated such measures at different frequency bands and computed different local graph parameters considering different proportional threshold values for a binary network analysis. After applying a feature selection procedure to determine the most relevant features for classification performance with a linear Support Vector Machine algorithm, our study demonstrates the effectiveness of the statistical entropy measure for analyzing the brain network in patients with different stages of cognitive dysfunction.

7 April 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NHNesma HOUMANI
Nesma HOUMANI
SGSonia Garcia-Salicetti
Sonia Garcia-Salicetti
Individuals behave differently regarding to biometric authentication systems. This fact was formalized in the literature by the concept of Biometric Menagerie, defining and labeling user groups with animal names in order to reflect their characteristics with respect to biometric systems. This concept was illustrated for face, fingerprint, iris, and speech modalities. The present study extends the Biometric Menagerie to online signatures, by proposing a novel methodology that ties specific quality measures for signatures to categories of the Biometric Menagerie. Such measures are combined for retrieving automatically writer categories of the extended version of the Biometric Menagerie. Performance analysis with different types of classifiers shows the pertinence of our approach on the well-known MCYT-100 database.

20 July 2023 in Sensors
Verified
Journal Article
Open access
PDF file
LHLorenzo HERMEZ
Lorenzo HERMEZ
AHAbdelghani Halimi
Abdelghani Halimi
NHNesma HOUMANI
Nesma HOUMANI
SGSonia Garcia-Salicetti
Sonia Garcia-Salicetti
OGOmar Antonio Galarraga
Omar Antonio Galarraga
vincent vigneronvincent vigneron
vincent vigneron
This study addresses the characterization of normal gait and pathological deviations induced by neurological diseases, considering knee angular kinematics in the sagittal plane. We propose an unsupervised approach based on Dynamic Time Warping (DTW) to identify different normal gait profiles (NGPs) corresponding to real cycles representing the overall behavior of healthy subjects, instead of considering an average reference, as done in the literature. The obtained NGPs are then used to measure the deviations of pathological gait cycles from normal gait with DTW. Hierarchical Clustering is applied to stratify deviations into clusters. Results show that three NGPs are necessary to finely characterize the heterogeneity of normal gait and accurately quantify pathological deviations. In particular, we automatically identify which lower limb is affected for Hemiplegic patients and characterize the severity of motor impairment for Paraplegic patients. Concerning Tetraplegic patients, different profiles appear in terms of impairment severity. These promising results are obtained by considering the raw description of gait signals. Indeed, we have shown that normalizing signals removes the temporal properties of signals, inducing a loss of dynamic information that is crucial for accurately measuring pathological deviations. Our methodology could be exploited to quantify the impact of therapies on gait rehabilitation.

4 February 2022 in Bioengineering
Verified
Journal Article
Open access
PDF file
MAMAJD ABAZID
MAJD ABAZID
NHNesma HOUMANI
Nesma HOUMANI
BDBernadette Dorizzi
Bernadette Dorizzi
JBJérôme Boudy
Jérôme Boudy
JMJEAN MARIANI
JEAN MARIANI
KKKiyoka Kinugawa
Kiyoka Kinugawa
This study addresses brain network analysis over different clinical severity stages of cognitive dysfunction using electroencephalography (EEG). We exploit EEG data of subjective cognitive impairment (SCI) patients, mild cognitive impairment (MCI) patients and Alzheimer’s disease (AD) patients. We propose a new framework to study the topological networks with a spatiotemporal entropy measure for estimating the connectivity. Our results show that functional connectivity and graph analysis are frequency-band dependent, and alterations start at the MCI stage. In delta, the SCI group exhibited a decrease of clustering coefficient and an increase of path length compared to MCI and AD. In alpha, the opposite behavior appeared, suggesting a rapid and high efficiency in information transmission across the SCI network. Modularity analysis showed that electrodes of the same brain region were distributed over several modules, and some obtained modules in SCI were extended from anterior to posterior regions. These results demonstrate that the SCI network was more resilient to neuronal damage compared to that of MCI and even more compared to that of AD. Finally, we confirm that MCI is a transitional stage between SCI and AD, with a predominance of high-strength intrinsic connectivity, which may reflect the compensatory response to the neuronal damage occurring early in the disease process.

21 March 2024 in Journal of Integrative Neuroscience
Verified
Journal Article
Open access
PDF file
KAKatia Andrade
Katia Andrade
NHNesma HOUMANI
Nesma HOUMANI
TGThomas Guieysse
Thomas Guieysse
SRSolofo Razafimahatratra
Solofo Razafimahatratra
AKAndré Klarsfeld
André Klarsfeld
TMTakfarinas Medani
Takfarinas Medani
Background: Electroencephalography (EEG) stands as a pivotal non-invasive tool, capturing brain signals with millisecond precision and enabling real-time monitoring of individuals’ mental states. Using appropriate biomarkers extracted from these EEG signals and presenting them back in a neurofeedback loop offers a unique avenue for promoting neural compensation mechanisms. This approach empowers individuals to skillfully modulate their brain activity. Recent years have witnessed the identification of neural biomarkers associated with aging, underscoring the potential of neuromodulation to regulate brain activity in the elderly. Methods and Objectives: Within the framework of an EEG-based brain-computer interface, this study focused on three neural biomarkers that may be disturbed in the aging brain: Peak Alpha Frequency, Gamma-band synchronization, and Theta/Beta ratio. The primary objectives were twofold: (1) to investigate whether elderly individuals with subjective memory complaints can learn to modulate their brain activity, through EEG-neurofeedback training, in a rigorously designed double-blind, placebo-controlled study; and (2) to explore potential cognitive enhancements resulting from this neuromodulation. Results: A significant self-modulation of the Gamma-band synchronization biomarker, critical for numerous higher cognitive functions and known to decline with age, and even more in Alzheimer’s disease (AD), was exclusively observed in the group undergoing EEG-neurofeedback training. This effect starkly contrasted with subjects receiving sham feedback. While this neuromodulation did not directly impact cognitive abilities, as assessed by pre- versus post-training neuropsychological tests, the high baseline cognitive performance of all subjects at study entry likely contributed to this result. Conclusion: The findings of this double-blind study align with a key criterion for successful neuromodulation, highlighting the significant potential of Gamma-band synchronization in such a process. This important outcome encourages further exploration of EEG-neurofeedback on this specific neural biomarker as a promising intervention to counter the cognitive decline that often accompanies brain aging and, eventually, to modify the progression of AD.